March 17, 2004

A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

Adjuvant chemotherapy has a significant survival benefit in patients with resected pancreatic cancer, whereas adjuvant chemoradiotherapy has a deleterious effect on survival.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Neoptolemos et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69d8bd25183921ebcaae37c3 — DOI: https://doi.org/10.1056/nejmoa032295

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial· 2001 · 631 citations
Hepatogastroenterology· 2012 · 3,202 citations
Trends in pancreatic cancer mortality in Europe, 1955–1989· 1994 · 114 citations
Relationship between hospital volume and late survival after pancreaticoduodenectomy· 1999 · 386 citations
Regression Models and Life-Tables

Authors

John P. Neoptolemos

Deborah Stocken

Helmut Friess

Journals

New England Journal of Medicine

Actions

Institutions

Heidelberg University

Sorbonne Université

University of Birmingham

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion